Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
391 Leser
Artikel bewerten:
(1)

European Wellness Biomedical Group, Headed by Prof. Mike Chan, Releases New Study on Bioregenerative Blueprint for Athletic Longevity

KOTA KINABALU, Malaysia, Dec. 2, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG), a global leader in regenerative medicine, has unveiled a groundbreaking study led by renowned expert Prof. Mike Chan on the physiological challenges aging athletes face. The analysis explores how age impacts athletic performance, highlighting how regenerative medicine can help extend careers and enhance performance for aging athletes.


"Aging shouldn't be a barrier to peak performance in sports, with stamina and endurance," says Prof. Mike Chan, who aims to redefine athletic potential through regenerative medicine.

The study reveals that aging significantly affects stamina, endurance, and balance in athletes. Prof. Chan's vision is to help athletes overcome age-related limits and maintain peak performance.

This comes after a recent high-profile boxing match where an aging legend faced a younger, more active opponent. Despite the legendary status of the older athlete, his performance was hindered by the physical decline caused by age, struggling to maintain intensity throughout the match. This sparked widespread discussions on how aging impacts athletes, especially in high-intensity sports, reinforcing the study's focus on how regenerative medicine can counteract these challenges.

Prof. Chan explains, "Aging affects not only muscles but also critical systems like the heart, lungs, and adrenal glands, which are vital for stamina and endurance."

The study identifies key areas affected by aging, beginning with the heart. "The heart begins to age around 40, and its efficiency can halve by age 70," notes Prof. Chan. "This decline directly impacts stamina, limiting an athlete's ability to sustain high levels of performance, especially in endurance sports."

The adrenal glands, crucial for bursts of energy and recovery, also decline with age. "Adrenal health is critical during intense physical exertion," explains Prof. Chan. "As these glands weaken, endurance and recovery slow down, reducing overall athletic output."

Brain health is another significant factor. Prof. Chan highlights how aging affects the hippocampus and prefrontal cortex, areas vital for coordination, reaction time, and decision-making. "Decline in these brain regions can make it harder for athletes to stay sharp under pressure," he says.

The recent boxing match, where an aging athlete struggled to compete against a younger, fitter opponent, serves as a poignant example of these issues. This further emphasizes Prof. Chan's belief that regenerative medicine is key to helping aging athletes overcome these limitations and perform at their highest level for longer.

Despite these challenges, Prof. Chan is optimistic about regenerative medicine's potential to reverse biological aging. "At European Wellness, we focus on the holistic rejuvenation of the heart, lungs, adrenal glands, and brain. Our systemic approach aims to enhance stamina, balance, and endurance, offering athletes a renewed capacity for peak performance," he explains.

"Without proactive intervention, the functional decline of these areas quickly affects overall performance," says Prof. Chan. "Regenerative medicine provides an opportunity to not only extend athletic careers but also to redefine what aging athletes can achieve."

EWBG continues to lead the way in regenerative medicine with its innovative treatments, by addressing the biological effects of aging. The European Wellness Premier Center in Kota Kinabalu is at the forefront of these advancements, helping individuals not only look youthful but also feel and perform better, regardless of age.

For more information on EWBG's pioneering work in regenerative medicine, visit https://european-wellness.eu

EW Group Logo

Photo - https://mma.prnewswire.com/media/2570606/Age_shouldn_t_a_barrier_peak_performance_stamina_endurance_Prof_Mike.jpg
Logo - https://mma.prnewswire.com/media/2362609/EW_COLOR_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/european-wellness-biomedical-group-headed-by-prof-mike-chan-releases-new-study-on-bioregenerative-blueprint-for-athletic-longevity-302319475.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.